New wisdom · 2019 pharmaceutical industry annual value pioneer list registration opened!

New wisdom · 2019 pharmaceutical industry annual value pioneer list registration opened! In 2019, new China ushered in its 70th birthday After 70 years of ups and downs, China's medical and health industry has undergone great changes and constructed a new pattern Focusing on the current situation, the policy "combination boxing" is in place; the "China speed" of drug review and approval is praised; the pace of investment in the biomedical industry is further accelerated; the internet medical industry also ushers in new breakthroughs In order to record the track of witnessing the change of the times, explore and find the power of example, Sina pharmaceutical, together with the think tank of food and drug industry (China), specially launched the selection activity of "new wisdom · 2019 pharmaceutical industry annual value pioneer list" The purpose of the selection is to find out the explorers and practitioners who have real value creation, maintain innovation vitality and have a positive impact on industrial change There are three categories of awards and seven lists Based on the principles of objectivity, impartiality and transparency, the medical industry will be scanned and examined professionally from the perspectives of people, enterprises, products and projects In addition, we will also select representative guests and enterprises to conduct research, interview and report, and strive to maximize the influence and value The selection and application channel has been officially opened on October 15, 2019 After online registration and recommendation, the finalists are determined to be nominated for evaluation The final award list consists of two parts: online voting (weight 50%) and expert evaluation (weight 50%) At the same time, the event will continue to integrate media resources, invite authoritative organizations to participate in the certification, and invite industry leaders and industry leaders to participate in the evaluation The final evaluation results will be announced in December The following are the participating Awards: people award 2019: the criteria for the participation of the annual vanguard in the pharmaceutical industry: 1 The business entity of the enterprise / institution where the participants are located is the official registered unit in China 2 Forward looking: the participants have a considerable position and influence in the industry, can provide new ideas and measures for the industry to move towards high-quality development, and have a strong role in promoting and driving the industry development 3 Vanguard: the participants have made great achievements in enterprise / institution management, talent training, R & D innovation, social responsibility, etc they can continuously enhance the endogenous power of enterprises / institutions, promote enterprises / institutions to become stronger, better and bigger, which is an industry development model 4 Excellence: the outstanding performance of the participants in 2019 is an advanced model of this year's great leap and remarkable achievements, which is widely recognized by the industry Selection rules: the final result is composed of two parts: online voting (weight: 50%) and expert evaluation (weight: 50%), and the winner list (10) is finally evaluated 2019 criteria for the participation of new and cutting-edge persons in the pharmaceutical industry: 1 The business entity of the enterprise / institution where the participants are located is the official registration unit in China 2 Innovation: the participants have a strong sense of independent innovation, and the products, technologies, projects and management models led by them or as the main responsible person are innovative and subversive in the industry, with outstanding social benefits 3 Competitiveness: the products, technologies, projects, etc led by the participants have strong industry competitiveness, significant actual effect, and good economic benefits or investment value 4 The outstanding performance of the participants in 2019 is the outstanding representative with many highlights and rapid progress in this year, and the priority of having independent intellectual property rights, core technology and innovation results Selection rules: the final result is composed of two parts: online voting (weight: 50%) and expert evaluation (weight: 50%), and the winner list (10) is finally evaluated Enterprise award 2019 standard for participation of benchmark enterprises in the pharmaceutical industry: 1 The business entity of the participating enterprises is officially registered enterprises in China, and the scale of enterprise assets currently exceeds 1 billion yuan, which has a certain influence in the industrial field of the pharmaceutical industry in China 2 The participating enterprises have made outstanding achievements in R & D, sales, profit, market share, growth scale and industrial progress in 2019 3 The participating enterprises pay attention to production safety, honest operation, law-abiding and compliance, and public welfare undertakings, which can give good consideration to the rights and interests of employees and occupational health, and have a good social demonstration role Note: participating enterprises can submit data of R & D, revenue, market value or valuation in recent three years, as well as projects under research, under approval or approved for reference Selection rules: after the preliminary online registration and recommendation, the selection will be nominated and evaluated The results are composed of two parts: online voting (weight 50%) and expert evaluation (weight 50%) Finally, the list of award-winning enterprises (10) will be evaluated 2019 criteria for the participation of the most valuable growing enterprises in the pharmaceutical industry: 1 The business entity of the participating enterprises is officially registered in China, with the establishment time of no more than 10 years, and the market value or valuation is currently more than 500 million yuan 2 The participating enterprises have the concept of independent R & D and innovation, which can effectively provide new solutions for the industry development and lead the future trend 3 The participating enterprises can actively adapt to the market demand, and their products, technologies, projects, etc have strong industry competitiveness, significant actual effect, and good economic benefits or investment value 4 The enterprises participating in the evaluation have a number of scientific and technological achievements recognition or awards such as growth power and innovation power Note: participating enterprises can submit data of R & D, revenue, financing amount, market value or valuation in recent three years, as well as projects under research, under approval or approved for reference Selection rules: after the preliminary online registration and recommendation, the selection will be nominated and evaluated The results are composed of two parts: online voting (weight 50%) and expert evaluation (weight 50%) Finally, the list of award-winning enterprises (10) will be evaluated Criteria for participating in the evaluation of chain drugstores in 2019: 1 The business entity of the participating enterprises is a officially registered enterprise in China, with an average annual sales of more than 300 million yuan in the past three years, which has a certain influence in the circulation field of China's pharmaceutical industry 2 In 2019, the participating enterprises performed well and were recognized in terms of corporate income, profit, market share and growth scale 3 The participating enterprises are widely recognized by users through high-quality products and services, and the brand awareness and reputation are constantly improved 4 The participating enterprises have innovation awareness, and have important innovation measures in product, technology, management, talent, development mode and many other aspects, which can play a leading role in industry reform and lead the future development trend Note: participating enterprises can submit the number of stores, coverage of medical insurance, sales, profit, market value or valuation data for reference in the past three years Selection rules: after the preliminary online registration and recommendation, the selection will be nominated and evaluated The results are composed of two parts: online voting (weight 50%) and expert evaluation (weight 50%) Finally, the list of award-winning enterprises (30) will be evaluated Product and Project Awards 2019 OTC brand participation criteria: 1 The products are listed products in China, with an average annual sales of more than 200 million yuan in the past three years, and their business entities are officially registered enterprises in China 2 In the competitive environment, the evaluated products can continuously adapt to the innovation and development of the policy environment, have core competitive advantages and competitive potential The annual sales volume is far ahead of the products of the same category, and the market share is very high 3 The quality of the evaluated products is well recognized by the masses, and the brand awareness and reputation are excellent, making outstanding contributions to promoting the national health level Note: the data of sales, profit and market scale in the past three years can be submitted for reference Selection rules: the final result is composed of two parts: online voting (weight: 50%) and expert evaluation (weight: 50%), and the final product list (30) is evaluated Criteria for participation in 2019 public welfare projects of the pharmaceutical industry: 1 The business entity of the enterprise / institution where the participants are located is the official registered unit in China 2 The participating projects are public relations practice activities sponsored and supported by enterprises / institutions in human, material and financial aspects 3 The performance of the project is outstanding in 2019, which has successfully brought together forces from all walks of life and effectively brought help to the recipients, with remarkable practical effect 4 The social influence of the project is extensive, which plays a good demonstration role for more enterprises / institutions, human and material resources to invest in public welfare undertakings Selection rules: the final results are composed of two parts: online voting (weight 50%) and expert evaluation (weight 50%), and the final list of award-winning items (10 items) is evaluated Registration method: ① click the website: https://med.sina.com/xuanti/2019pingxuan/index.html to enter the registration page; ② scan the QR code below to enter the registration page; ③ follow the official wechat of sina Pharmaceutical (wechat: sinayiyao), click the menu "2019 selection" to participate in the registration Registration time: October 15, 2019 to November 15, 2019 consultation Tel: 010-61934050-818 guidance unit: China Pharmaceutical Materials Association sponsor: Sina Pharmaceutical News, (China) think tank media support in the food and drug industry: (ranking in no order, continuous updating...)